- Directors and Auditors
- Articles of Association
- General Meetings
- - Previous General Meetings
- Insider Trading
Deloitte ranks Dignitana AB as one of the fastest growing technology companies
Dignitana AB, a world leader in medical scalp-cooling technology for reducing hair loss related to chemotherapy, is pleased to announce that Dignitana is ranked in the Sweden Technology Fast 50 ranking list by Deloitte, an international consulting firm.
“We feel honored to be nominated and ranked as one of the fastest growing technology companies by Deloitte. We’ve grown during the ranking’s period, and we have fantastic journey in front of us with United States Food and Drug Administration approval pending.” says Jan Richardsson, CEO, Dignitana AB.
About Deloitte Sweden Technology Fast 50 and Rising Stars
The only cross-industry ranking of technology companies in Sweden. The award is now in its eleventh year. The ranking includes public and private companies, large and small, in all areas of technology, from Internet specialists to life sciences, green tech, computers to semiconductors and software to telecommunications. Growth is based on revenue growth over the last five years according to annual reports reported to Bolagsverket per 31 July. For Fast 50 the growth is measured during 2009-2013, and for Rising Stars during 2011-2013. Please find more detailed information (in Swedish) on www.deloitte.se/fast50.
CEO, Dignitana AB (publ)
Ph 46 (0)46 16 30 92
About Dignitana AB (publ)
Dignitana is a Swedish public company, based in Lund, and manufacturer of medical cooling devices. Our core product - the DigniCap® System - is a patented scalp-cooling system for preventing or reducing hair loss for chemotherapy patients. Dignitana is continuously researching and developing new products and use for the DigniCap® System. Dignitana AB is listed on the OMX Nasdaq First North Stockholm. For more information visit www.dignitana.com
About the DigniCap® System
The DigniCap® System protects cells, and ultimately your hair, by reducing the concentration of chemotherapy being delivered to your scalp area. The DigniCap® System is developed to provide continuous cooling with high efficacy, safety and acceptable patient comfort.